Finance

Lists
300760:SHE
Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CNÂ¥165.35
+0.64%
(+1.05) 1D
Aug 31, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300760...
Open
CNÂ¥168.00
High
CNÂ¥169.90
Low
CNÂ¥165.17
Mkt. cap
199.10B
Avg. vol.
10.04M
Volume
0.00
Dividend
2.22%
Quarterly dividend
CNÂ¥0.92
Ex-dividend date
May 28, 2026
P/E ratio
25.57
52-wk high
CNÂ¥252.95
52-wk low
CNÂ¥130.66
EPS
CNÂ¥6.47
Shares outstanding
1.21B
No. of employees
21K
Open
CNÂ¥168.00
High
CNÂ¥169.90
Low
CNÂ¥165.17
Mkt. cap
199.10B
Avg. vol.
10.04M
Volume
0.00
Dividend
2.22%
Quarterly dividend
CNÂ¥0.92
Ex-dividend date
May 28, 2026
P/E ratio
25.57
52-wk high
CNÂ¥252.95
52-wk low
CNÂ¥130.66
EPS
CNÂ¥6.47
Shares outstanding
1.21B
No. of employees
21K
Profile
Mindray Bio-Medical Electronics Co., Ltd., simply known as Mindray, is a Chinese multinational health technology company based in Shenzhen, Guangdong. Mindray designs and produces medical equipment and accessories for both human and veterinary use. The company is organized into three key business lines: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was recognized as China's largest medical device manufacturer. Wikipedia
About Shenzhen Mindray Bio-Medl Elctrnc Co Ltd
CEO-
Employees21.3K
Founded1991
Headquarters-
SectorMedical device
Websitemindray.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
9.09B
7.45B
8.35B
9.39B
Cost of goods sold
3.32B
3.70B
3.18B
3.77B
Cost of revenue
3.32B
3.70B
3.18B
3.77B
Research and development expenses
828.27M
1.14B
801.74M
767.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.68B
1.91B
1.58B
1.63B
Operating expense
2.53B
3.19B
2.39B
2.40B
Total operating expenses
5.85B
6.89B
5.57B
6.17B
Operating income
3.24B
563.02M
2.78B
3.23B
Other non operating income
-38.60M
13.79M
-332.20M
-66.24M
EBT including unusual items
2.98B
772.35M
2.54B
3.01B
EBT excluding unusual items
3.16B
581.57M
2.57B
3.06B
Income tax expense
403.50M
134.78M
114.81M
394.38M
Effective tax rate
13.52%
17.45%
4.52%
13.08%
Other operating expenses
-8.48M
90.41M
-9.50M
13.03M
Net income
2.50B
565.73M
2.33B
2.47B
Net profit margin
27.51%
7.60%
27.89%
26.26%
Earnings per share
2.07
-
-
-
Interest and investment income
132.38M
125.46M
124.39M
6.07M
Interest expense
-6.45M
-7.27M
-6.07M
-104.41M
Net interest expenses
125.93M
118.19M
118.32M
-98.34M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.57B
951.35M
3.17B
3.66B
Gain or loss from assets sale
736.57K
-10.72M
-
9.02M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps